HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

BCH-1868 [(-)-2-R-dihydroxyphosphinoyl-5-(S)-(guanin-9'-yl-methyl) tetrahydrofuran]: a cyclic nucleoside phosphonate with antitumor activity.

Abstract
Nucleoside phosphonates are widely used therapeutic agents with a broad spectrum of antiviral activity. However, only a few of them are reported to have antitumor activity. In this study, we show that a tetrahydrofuran phosphonate analogue of guanosine, (-)-2-R-dihydroxyphosphinoyl-5-(S)-(guanin-9'-ylmethyl) tetrahydrofuran (BCH-1868), previously reported as having antiviral activity, also displays antitumor activity. In vitro, BCH-1868 inhibited the proliferation of several murine and human cancer cell lines with IC50s in the microM range independently of the tissue type or the presence of multidrug resistance protein MRP/gp190. In vivo, BCH-1868 was active against a variety of human tumor xenograft models (Caki-1, HT-29, DU 145, COLO 205, and CCRF-CEM). In all tumors tested, a significant tumor growth inhibition was noted at 40-50 mg/kg (daily x 5), but no tumor regression was observed in the settings used. To better understand these results, we partially characterized, at the cellular level, the mechanism of action of this new cyclic nucleoside phosphonate and investigated its pharmacokinetic characteristics in mice. We showed that BCH-1868 exerts its antitumor activity by an inhibitory mechanism at the level of DNA polymerase a, resulting in arrest of DNA synthesis and a block of cell division at the S phase of the cell cycle. Low-circulating plasma concentration (Cmax = 87 microM; area under the curve = 1138 micromol x min/liters; after a bolus i.v. injection of 10 mg/kg) and rapid clearance of the drug (terminal half-life, t1/2 = 16 min) may contribute to the modest antitumor efficacy observed in vivo.
AuthorsLorraine Leblond, Giorgio Attardo, Bettina Hamelin, David Y Bouffard, Nghe Nguyen-Ba, Henriette Gourdeau
JournalMolecular cancer therapeutics (Mol Cancer Ther) Vol. 1 Issue 9 Pg. 737-46 (Jul 2002) ISSN: 1535-7163 [Print] United States
PMID12479370 (Publication Type: Journal Article)
Chemical References
  • 2-dihydroxyphosphinoyl-5-(guanin-9'-ylmethyl)tetrahydrofuran
  • Antineoplastic Agents
  • Antiviral Agents
  • Phosphinic Acids
  • Guanine
  • DNA Polymerase I
Topics
  • Animals
  • Antineoplastic Agents (pharmacokinetics)
  • Antiviral Agents (pharmacology)
  • Cell Cycle
  • Cell Division
  • DNA Polymerase I (antagonists & inhibitors)
  • Dose-Response Relationship, Drug
  • Guanine (analogs & derivatives, pharmacokinetics)
  • Humans
  • Inhibitory Concentration 50
  • Liver (metabolism)
  • Mice
  • Mice, Nude
  • Mice, SCID
  • Models, Chemical
  • Neoplasm Transplantation
  • Phosphinic Acids (pharmacokinetics)
  • Time Factors
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: